Scientific Sessions 2024  /  Building on the 4 Pillars: Novel Trials of Medical Therapy for Heart Failure  /  Discussant: The SARAH Trial
Logo

American Heart Association

  2
  0

Final ID:

Discussant: The SARAH Trial

  • Lopez-fernandez, Teresa  ( La Paz University Hospital, IdiPAZ , Madrid , Spain )
  • Ky, Bonnie  ( UNIV OF PENN SCH OF MED , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Teresa Lopez-Fernandez: DO have relevant financial relationships ; Speaker:Philips:Past (completed) ; Advisor:myocardial solutions:Active (exists now) ; Advisor:beigene:Active (exists now) ; Advisor:astra zaneca:Active (exists now) ; Advisor:janssen:Active (exists now) ; Speaker:janssen:Past (completed) ; Speaker:pfizer:Past (completed) ; Speaker:daiichy-sankyo:Past (completed) ; Speaker:Bayer:Past (completed) ; Advisor:philips:Active (exists now) | Bonnie Ky: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Impulse Dynamics (Echo Core Lab):Active (exists now) ; Consultant:Pfizer :Past (completed) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:BMS:Past (completed) ; Consultant:Roche:Past (completed) ; Other (please indicate in the box next to the company name):Pfizer (IIS):Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Building on the 4 Pillars: Novel Trials of Medical Therapy for Heart Failure

Monday, 11/18/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial – The SARAH Trial

Bonatto Marcely, Zaninelli Maiolino Julyana, Mosko Larissa Arlete, Mialski Talita, Ota Tammy, Moura Lidia, Cauduro Sanderson, Bocchi Edimar, Ferreira Silvia, Avila Monica, Lechinewski Luka, Torres Rafael, Costa Amanda, Coiradas Andressa, Costa Nadya, Contin Lais

Novel Bumetanide Nasal Spray (BNS) Demonstrates Safety, Tolerability, and Equivalent Efficacy Compared to Intravenous and Oral Bumetanide

Kolski Brian, Bensimhon Daniel, Adler Eric, Kapur Navin, Lala Anuradha, Macaluso Gregory, Hajduczok Alexander, Neutel Joel

More abstracts from these authors:
Guidelines in Cardio-Oncology: Ready for Prime Time? (Con)

Witteles Ronald, Ky Bonnie, Upshaw Jenica

Panel Discussion

Lau Emily, Hochman Judith, Brewer Laprincess, Michos Erin, Sutton Nadia, Ky Bonnie, Quesada Odayme, Reza Nosheen

You have to be authorized to contact abstract author. Please, Login
Not Available